BRIEF — Impact Therapeutics Says Senaparib Submitted To European Commission For Final Marketing Authorization Decision
Sept 18 (Reuters) — IMPACT Therapeutics Inc: Senaparib Submitted To European Commission For Final Marketing Authorization Decision Further company coverage: 7630.HK (Reuters.Briefs@thomsonreuters.com;)